Another recent analysis included patients from the RTOG 9704 trial (Bitterman et al., 2021) and showed that T2DM, insulin use, and obesity had no associations with OS in patients with PC but noted a significantly lower survival rate in nonwhite patients. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.